Psoriasis
main-banner
Psoriasis
CAIN457ACA06 Enrolling

Adults Psoriasis Study (2 Months)


Age: 18 Years


Who Can Participate?

Adults with moderate to severe plaque psoriasis may participate.

Inclusion Criteria

  • Moderate-to-severe plaque psoriasis adult patients who are candidates for certain advanced treatments, known as biologic disease-modifying antirheumatic drugs (bDMARDs) as per provincial reimbursement criteria
  • Residents of Canada

What Are The Benefits?

  • No cost to participate
  • Regular visits with study doctors who specialise in treating psoriatic disease (or psoriasis and psoriatic arthritis) as there is one visit at the Dermatologist, one visit at the Rheumatologist and a phone call from the Dermatologist.
  • Reimbursement for study-related expenses may be provided

How Long Will The Study Last?

  • 10 weeks

 


Participating Locations

COUNTRY
country-icon
Canada

Participating Experts

No Doctors Found

You May Also Be Interested In

Similar Trials

No Similar Trials Found

The following information is from ClinicalTrials.gov

Last Update Posted: June 16, 2025

Official Title

A Multicenter, Prospective, Study to Evaluate the Impact of Modifying the Validated Psoriasis Epidemiology Screening Tool (PEST) on the Potential Diagnosis of Psoriatic Arthritis in Adult Patients With Moderate-to-severe Plaque Psoriasis in Canada ("ScreenX")

ClinicalTrials.gov ID

NCT06382051

Sponsor

Novartis Pharmaceuticals

Study Description

  • Brief Summary:

    The purpose of this study is to assess the impact of adding two questions and pictures to the validated PEST on the potential diagnosis of PsA in participants with moderate-to-severe plaque PsO in Canada.

  • Condition or Disease:

    Plaque Psoriasis,Psoriatic Arthritis

  • Intervention/Treatment:

    Diagnostic Test: PEST Screening group
  • Phase:

    NA

  • Ages Eligible for Study:

    18 Years and older (ADULT,OLDER_ADULT)

  • Sexes Eligible for Study:

    ALL


Terms and Conditions – ClinicalTrials.gov
Purpose of ClinicalTrials.gov Database. The U.S. National Institutes of Health, Department of Health and Human Services, through its National Library of Medicine, has developed ClinicalTrials.gov to provide patients, family members, and members of the public current information about clinical research studies.



about-icon

Learn More About

Psoriasis

Learn More
2025 all rights reserved Probity Medical Research Inc
find a trial
General Registration

Can’t find a trial? Not sure which trial to choose? Complete a general registration and we’ll contact you with suitable trials.

Register
filter trials
Skip to content